---
schema_version: "secwatch.filing_event.v1"
accession: "0001217234-24-000101"
form_type: "8-K"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T05:48:24.828909+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CareDx Q3 revenue $82.9M (+23% YoY), raises FY guidance to $327-331M with positive EBITDA $6.9M

## Summary
- Revenue $82.9M (+23% YoY); testing services rev $60.8M (+27%); volume 44,600 tests (+16%).
- GAAP net loss $7.4M improved from -$23.5M; non-GAAP net income $8.0M; positive adjusted EBITDA $6.9M.
- Raised FY2024 revenue guidance to $327-331M (from $320-328M) and adjusted EBITDA to $18-22M (from $9-15M).
- DOJ concluded investigation with no finding of wrongdoing; CMS reaffirmed coverage for AlloSure/AlloMap.
- Cash $241M, no debt; hired new COO, CCO, and Chief Data/AI Officer.

## SEC filing metadata
- accession: 0001217234-24-000101
- form_type: 8-K
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000121723424000101/0001217234-24-000101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000121723424000101/cdna-20241104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001217234-24-000101
- JSON: https://secwatch.observer/filing/0001217234-24-000101.json
- Plain text: https://secwatch.observer/filing/0001217234-24-000101.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.